Blogs | Scorpius

Extending Your Cash Runway with Lean Clinical Manufacturing

Lean clinical manufacturing streamlines the path to the clinic, extending a biotech’s cash runway through a phase-appropriate approach to process development.

Non-Dilutive Funding—An Excellent Option for Biotech Startups

Sources of non-dilutive funding to advance early-stage biotech programs through clinical trial manufacturing, from biologics CDMO Scorpius BioManufacturing

Bench To The Clinic: Biomanufacturing 101 for University Researchers

Discover how Scorpius BioManufacturing can assist University researchers in navigating translational biomanufacturing.

How to Create a Successful Business and Technical Relationship with a CDMO

Scorpius BioManufacturing shares customer input on what makes for a successful business and technical relationship between sponsors and biologics CDMO.

February 6, 2024

How to Select the Right Biologics CDMO Partner

The article discusses essential & strategic considerations throughout the biologics CDMO selection process, including weighing options to make the best decisions.

December 1, 2023

Evaluating Biologics CDMOs: Tips for Crafting an RFP

Suggestions for designing an effective RFP for a biologics CDMO selection process, including how to approach RFP design & the information it should gather.

November 14, 2023

5 New Questions to Ask Before Signing with a Biologics CDMO

This article discusses the current value biologics CDMOs bring to their innovator customers and new questions for selecting a CDMO partner.

October 17, 2023

Top 6 Questions to Ask When Evaluating a Biologics CDMO

When selecting a biologics CDMO partner, an innovator must ask the right questions to make the best decision. This article shares six top considerations.

September 12, 2023

3 Trends Innovative Biologics CDMOs Are Embracing

Deep Dive: Top 3 Biologics Trends Shaping the Future with Scorpius.

Scorpius Highlighted In Drug Development & Delivery's Annual Report

Scorpius highlighted in Drug Development & Delivery's annual CDMO report